KBC Group NV raised its position in shares of Henry Schein Inc. (NASDAQ:HSIC) by 24.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 53,380 shares of the company’s stock after buying an additional 10,396 shares during the period. KBC Group NV owned about 0.07% of Henry Schein worth $8,700,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Bank of New York Mellon Corp boosted its stake in Henry Schein by 0.4% in the third quarter. Bank of New York Mellon Corp now owns 770,651 shares of the company’s stock worth $125,601,000 after buying an additional 3,333 shares during the last quarter. Victory Capital Management Inc. boosted its stake in Henry Schein by 63.3% in the third quarter. Victory Capital Management Inc. now owns 7,195 shares of the company’s stock worth $1,173,000 after buying an additional 2,790 shares during the last quarter. Aperio Group LLC boosted its stake in Henry Schein by 2.0% in the third quarter. Aperio Group LLC now owns 57,647 shares of the company’s stock worth $9,395,000 after buying an additional 1,127 shares during the last quarter. Three Peaks Capital Management LLC boosted its stake in Henry Schein by 7.0% in the third quarter. Three Peaks Capital Management LLC now owns 32,081 shares of the company’s stock worth $5,229,000 after buying an additional 2,086 shares during the last quarter. Finally, Arizona State Retirement System boosted its stake in Henry Schein by 0.4% in the third quarter. Arizona State Retirement System now owns 51,800 shares of the company’s stock worth $8,442,000 after buying an additional 200 shares during the last quarter. Institutional investors and hedge funds own 91.35% of the company’s stock.

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Shares of Henry Schein Inc. (NASDAQ:HSIC) traded up 0.86% during trading on Tuesday, reaching $152.66. The company had a trading volume of 426,566 shares. The company has a market cap of $12.29 billion, a price-to-earnings ratio of 25.35 and a beta of 1.09. Henry Schein Inc. has a 12 month low of $142.64 and a 12 month high of $183.00. The firm has a 50 day moving average price of $154.22 and a 200 day moving average price of $166.36.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Wednesday, November 2nd. The company reported $1.68 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.65 by $0.03. The firm earned $2.87 billion during the quarter, compared to analysts’ expectations of $2.88 billion. Henry Schein had a return on equity of 18.15% and a net margin of 4.40%. The company’s revenue was up 6.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.55 EPS. Analysts predict that Henry Schein Inc. will post $6.58 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “Henry Schein Inc. (HSIC) Shares Bought by KBC Group NV” was originally reported by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are viewing this news story on another publication, it was stolen and reposted in violation of US & international copyright and trademark laws. The correct version of this news story can be read at https://www.thecerbatgem.com/2016/11/29/henry-schein-inc-hsic-shares-bought-by-kbc-group-nv.html.

A number of research firms recently issued reports on HSIC. Leerink Swann reissued a “hold” rating on shares of Henry Schein in a research report on Thursday, November 3rd. Zacks Investment Research raised Henry Schein from a “sell” rating to a “hold” rating in a research report on Friday, November 4th. Bank of America Corp. assumed coverage on Henry Schein in a research report on Monday, September 12th. They issued a “buy” rating and a $185.00 price target for the company. Robert W. Baird reaffirmed an “outperform” rating and issued a $176.00 price target (up previously from $175.00) on shares of Henry Schein in a research report on Tuesday, October 4th. Finally, Goldman Sachs Group Inc. raised Henry Schein from a “neutral” rating to a “buy” rating and set a $185.00 price target for the company in a research report on Tuesday, October 11th. Seven investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $172.83.

In other Henry Schein news, EVP Mark E. Mlotek sold 2,417 shares of the stock in a transaction dated Thursday, November 3rd. The stock was sold at an average price of $155.19, for a total transaction of $375,094.23. Following the completion of the transaction, the executive vice president now owns 40,456 shares in the company, valued at approximately $6,278,366.64. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 1.27% of the company’s stock.

About Henry Schein

Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.

5 Day Chart for NASDAQ:HSIC

Receive News & Stock Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related stocks with our FREE daily email newsletter.